Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor
2001 • 542 citations
CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12
2005 • 244 citations
The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone
2004 • 221 citations
Matrix Metalloproteinase Activity, Bone Matrix Turnover, and Tumor Cell Proliferation in Prostate Cancer Bone Metastasis
2002 • 221 citations
Biochemical and Pharmacological Criteria Define Two Shedding Activities for TRANCE/OPGL That Are Distinct from the Tumor Necrosis Factor α Convertase
2001 • 133 citations
Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells
2005 • 114 citations
Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue
2005 • 113 citations
Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism‐based selective gelatinase inhibitor
2005 • 94 citations
A Potential Oncogenic Activity of Platelet-Derived Growth Factor D in Prostate Cancer Progression
2004 • 93 citations
Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
1999 • 91 citations
Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase
2007 • 71 citations